Home Oligoclonal bands and immunoglobulin isotype switch during monitoring of patients with multiple myeloma and autologous hematopoietic cell transplantation: a 16-year experience
Article
Licensed
Unlicensed Requires Authentication

Oligoclonal bands and immunoglobulin isotype switch during monitoring of patients with multiple myeloma and autologous hematopoietic cell transplantation: a 16-year experience

  • Mariel Emilce Alejandre , Leticia Bibiana Madalena , Miguel Arturo Pavlovsky , Maria Laura Facio , Claudia Corrado , Gustavo Milone , Pablo Diego Bresciani , Susana Alicia Fraind , Santiago Pavlovsky and Marco Antonio Pizzolato
Published/Copyright: May 1, 2010

Abstract

Background: Over the last 20 years, high dose therapy followed by hemopoietic stem cell transplantation has been employed in patients with multiple myeloma (MM). During 16 years of follow-up, the degree of tumor response and survival in 238 patients with autologous stem cell transplantation (ASCT) and changes in the serum protein electrophoretic pattern were analyzed.

Methods: Agarose gel electrophoresis with densitometric analysis and immunofixation were performed to evaluate serum monoclonal protein. IgM, IgA, IgG and β2-microglobulin (β2M) were quantitated. Urine protein electrophoresis with IF was performed on cellulose acetate gel using colloidal silver staining without concentrating.

Results: After 34 months of follow-up (range 1–160 months), eight patients (3.4%) showed a distinct monoclonal protein band that was different from their original isotype switch. This was observed to be a transient phenomenon (22.2 months). Thirty-seven patients (15.5%) developed oligoclonal bands (OB) between the first and the twentieth month after ASCT (mean 4.4 months), which persisted for 7.9 months (1–36 months). The mean overall survival time was statistically different (p<0.05) between the group with OB and the group without them. Mean values of serum albumin, β2M, and non-involved immunoglobulins did not show statistical differences.

Conclusions: The occurrence of OB could be a potential favorable prognostic marker after transplantation due to the prolonged survival observed. Close follow-up of anomalous protein bands, either in serum or urine, is essential due to the additional difficulty in interpretation when the therapeutic response and evolution are evaluated.

Clin Chem Lab Med 2010;48:727–31.


Corresponding author: Dra. Mariel E. Alejandre, Department of Clinical Biochemistry, School of Pharmacy and Biochemistry, University of Buenos Aires, Junin 1284, Buenos Aires, CP 1113, Argentina Phone/Fax: +11-4821-4953,

Received: 2009-6-10
Accepted: 2009-10-11
Published Online: 2010-05-01
Published in Print: 2010-05-01

©2010 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorials
  2. Laboratory medicine and natural disasters: are we ready for the challenge?
  3. Reference values: still a critical issue in laboratory medicine
  4. Review
  5. Contemporary platelet function testing
  6. Minireviews
  7. Disasters: where they find us
  8. Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fall
  9. Opinion Paper
  10. Glycated hemoglobin (HbA1c): old dogmas, a new perspective?
  11. Guidelines and Recommendations
  12. IFCC reference procedures for measurement of the catalytic concentrations of enzymes: corrigendum, notes and useful advice
  13. Recommendations for the implementation of international standardization of glycated hemoglobin in Italy
  14. Genetics and Molecular Diagnostics
  15. UGT2B17 and SULT1A1 gene copy number variation (CNV) detection by LabChip microfluidic technology
  16. Genetic polymorphisms of CYP1A2, CYP3A4, CYP3A5, pregnane/steroid X receptor and constitutive androstane receptor in 207 healthy Spanish volunteers
  17. Automated genomic DNA extraction from saliva using the QIAxtractor
  18. General Clinical Chemistry and Laboratory Medicine
  19. A new statistical method for evaluating long-term analytical performance of laboratories applied to an external quality assessment scheme for flow cytometry
  20. Evaluation of the Becton-Dickinson rapid serum tube: does it provide a suitable alternative to lithium heparin plasma tubes?
  21. Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders
  22. Evaluation of the new body fluid mode on the Sysmex XE-5000 for counting leukocytes and erythrocytes in cerebrospinal fluid and other body fluids
  23. Extracellular haemoglobin, oxidative stress and quality of red blood cells relative to perioperative blood salvage
  24. Positive predictive value of serological diagnostic measures in celiac disease
  25. Retinol potentiates the inhibitory effect of ascorbic acid on uric acid assay
  26. Reference Values and Biological Variations
  27. Reference intervals for brain natriuretic peptide in healthy newborns and infants measured with an automated immunoassay platform
  28. Factors influencing serum total tryptase concentrations in a general adult population
  29. Leptin and adiponectin levels in pubertal children: relationship with anthropometric variables and body composition
  30. Cardiovascular risk factors and γ-glutamyltransferase fractions in healthy individuals
  31. Cancer Diagnostics
  32. Combined analysis of survivin autoantibody and carcinoembryonic antigen biomarkers for improved detection of colorectal cancer
  33. Oligoclonal bands and immunoglobulin isotype switch during monitoring of patients with multiple myeloma and autologous hematopoietic cell transplantation: a 16-year experience
  34. Letters to the Editor
  35. Methodological weakness in using correlation coefficients for assessing the interchangeability of analyte data between samples collected under different sampling conditions – the example of matrix metalloproteinase 9 determined in serum and plasma samples
  36. Intralipid causes falsely increased glucose concentrations with the Hemocue glucose analyzer
  37. Serum cholesterol: required and actual bias values
  38. Abstracts
  39. ISMD2010 Eighth International Symposium on Molecular Diagnostics
Downloaded on 6.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2010.050/pdf
Scroll to top button